Zai Lab Q1 2024 GAAP EPS $(0.55) Beats $(0.94) Estimate, Sales $87.10M Beat $75.24M Estimate
Portfolio Pulse from Benzinga Newsdesk
Zai Lab (NASDAQ:ZLAB) reported Q1 2024 GAAP EPS of $(0.55), surpassing the $(0.94) estimate, with sales of $87.10M exceeding the $75.24M forecast. This represents a 38.70% increase in sales compared to the same period last year.
May 08, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zai Lab reported a significant beat on both EPS and sales estimates for Q1 2024, with a notable year-over-year sales growth.
Beating both EPS and sales estimates significantly, especially with a substantial year-over-year sales increase, is likely to be viewed positively by investors. This could lead to increased investor confidence and potentially drive up Zai Lab's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100